Adamed Pharma S.A. Synthon Hispania S.L. Synthon s.r.o.

Poland

All drugs from this manufacturer

  • BORTEZOMIB ADAMED

    The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes) in individuals at least 18 years old.

    Dosage form: powder for preparation of injection solution

    Active substance Dosage
    bortezomib 3.5 mg

    ATC: L01XX32

  • BORTEZOMIB ADAMED

    The medicine is used to treat multiple myeloma (a type of bone marrow cancer) in adults and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).

    Dosage form: powder for preparation of injection solution

    Active substance Dosage
    bortezomib 2.5 mg

    ATC: L01XX32